Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Chrysalyne Delling Schmults, M.D.

Co-Author

This page shows the publications co-authored by Chrysalyne Schmults and Emily Ruiz.
Connection Strength

10.442
  1. Adjuvant radiation following clear margin resection of high T-stage cutaneous squamous cell carcinoma halves the risk of local and locoregional recurrence: A dual center retrospective study. J Am Acad Dermatol. 2022 Mar 29.
    View in: PubMed
    Score: 0.995
  2. Reply to "Rational Radiotherapy: The Role in Node-negative Squamous Cell Carcinoma". J Am Acad Dermatol. 2019 Oct 04.
    View in: PubMed
    Score: 0.838
  3. Surgery and Salvage Limited-Field Irradiation for Control of Cutaneous Squamous Cell Carcinoma With Microscopic Residual Disease. JAMA Dermatol. 2019 Oct 01; 155(10):1193-1195.
    View in: PubMed
    Score: 0.837
  4. Evaluation of the utility of localized adjuvant radiation for node-negative primary cutaneous squamous cell carcinoma with clear histologic margins. J Am Acad Dermatol. 2020 Feb; 82(2):420-429.
    View in: PubMed
    Score: 0.826
  5. Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women's Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma. JAMA Dermatol. 2019 07 01; 155(7):819-825.
    View in: PubMed
    Score: 0.823
  6. Analysis of national skin cancer expenditures in the United States Medicare population, 2013. J Am Acad Dermatol. 2019 Jan; 80(1):275-278.
    View in: PubMed
    Score: 0.757
  7. Multiple Mohs micrographic surgery is the most common reason for divergence from the appropriate use criteria: A single institution retrospective cohort study. J Am Acad Dermatol. 2016 Oct; 75(4):830-831.
    View in: PubMed
    Score: 0.680
  8. The positive impact of radiologic imaging on high-stage cutaneous squamous cell carcinoma management. J Am Acad Dermatol. 2017 Feb; 76(2):217-225.
    View in: PubMed
    Score: 0.680
  9. Impact of COVID-19 delays on skin cancer worry and Mohs micrographic surgery for keratinocytic carcinoma. J Am Acad Dermatol. 2021 Dec 04.
    View in: PubMed
    Score: 0.243
  10. Identifying Brigham and Women's Hospital stage T2a cutaneous squamous cell carcinomas at risk of poor outcomes. J Am Acad Dermatol. 2021 Dec 02.
    View in: PubMed
    Score: 0.243
  11. Higher metastasis and death rates in cutaneous squamous cell carcinomas with lymphovascular invasion. J Am Acad Dermatol. 2022 04; 86(4):766-773.
    View in: PubMed
    Score: 0.242
  12. A Systematic Review of Primary, Adjuvant, and Salvage Radiation Therapy for Cutaneous Squamous Cell Carcinoma. Dermatol Surg. 2021 05 01; 47(5):587-592.
    View in: PubMed
    Score: 0.234
  13. Provision of Trainee Biographies to Patients Before Mohs Micrographic Surgery Is Associated With Greater Patient Involvement by Trainees. Dermatol Surg. 2021 05 01; 47(5):706-708.
    View in: PubMed
    Score: 0.234
  14. Brigham and Women's Hospital tumor classification system for basal cell carcinoma identifies patients with risk of metastasis and death. J Am Acad Dermatol. 2021 09; 85(3):582-587.
    View in: PubMed
    Score: 0.229
  15. Efficacy and Cost Analysis for Acitretin for Basal and Squamous Cell Carcinoma Prophylaxis in Renal Transplant Recipients. Dermatol Surg. 2021 01 01; 47(1):125-126.
    View in: PubMed
    Score: 0.228
  16. Field cancerization: Treatment. J Am Acad Dermatol. 2020 Sep; 83(3):719-730.
    View in: PubMed
    Score: 0.218
  17. Histologic perineural invasion of unnamed nerves does not affect basal cell carcinoma outcomes. J Am Acad Dermatol. 2020 Jun; 82(6):1528-1530.
    View in: PubMed
    Score: 0.215
  18. Association of Rising Cost and Use of Oral Anticancer Drugs With Medicare Part D Spending From 2013 Through 2017. JAMA Oncol. 2020 01 01; 6(1):154-156.
    View in: PubMed
    Score: 0.213
  19. Detection of subclinical disease with baseline and surveillance imaging in high-risk cutaneous squamous cell carcinomas. J Am Acad Dermatol. 2020 Apr; 82(4):920-926.
    View in: PubMed
    Score: 0.211
  20. A matched-pair study of cutaneous squamous cell carcinomas with and without lymphovascular invasion. J Am Acad Dermatol. 2020 Apr; 82(4):1001-1003.
    View in: PubMed
    Score: 0.210
  21. Cost and utilization of immunotherapy and targeted therapy for melanoma: Cross-sectional analysis in the Medicare population, 2013 and 2015. J Am Acad Dermatol. 2020 03; 82(3):761-764.
    View in: PubMed
    Score: 0.210
  22. Factors predictive of recurrence, metastasis, and death from primary basal cell carcinoma 2 cm or larger in diameter. J Am Acad Dermatol. 2020 Sep; 83(3):832-838.
    View in: PubMed
    Score: 0.210
  23. Identification of skin cancer screening visits by using claims data. J Am Acad Dermatol. 2020 02; 82(2):504-505.
    View in: PubMed
    Score: 0.208
  24. A comparison of skin cancer screening and treatment costs at a Massachusetts cancer center, 2008 versus 2013. J Am Acad Dermatol. 2018 Nov; 79(5):921-928.
    View in: PubMed
    Score: 0.192
  25. Clinical and Incidental Perineural Invasion of Cutaneous Squamous Cell Carcinoma: A Systematic Review and Pooled Analysis of Outcomes Data. JAMA Dermatol. 2017 08 01; 153(8):781-788.
    View in: PubMed
    Score: 0.180
  26. Implications of Satellitosis or In-transit Metastasis in Cutaneous Squamous Cell Carcinoma: A Prognostic Omission in Cancer Staging Systems. JAMA Dermatol. 2022 Feb 23.
    View in: PubMed
    Score: 0.062
  27. Total Margin-Controlled Excision is Superior to Standard Excision for Keratinocyte Carcinoma on the Nose: A Veterans Affairs Nested Cohort Study. Ann Surg Oncol. 2021 Jul; 28(7):3656-3663.
    View in: PubMed
    Score: 0.058
  28. Field cancerization: Looking to the future. J Am Acad Dermatol. 2021 07; 85(1):e43-e44.
    View in: PubMed
    Score: 0.058
  29. Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI). Br J Cancer. 2020 11; 123(10):1535-1542.
    View in: PubMed
    Score: 0.056
  30. Field cancerization: Definition, epidemiology, risk factors, and outcomes. J Am Acad Dermatol. 2020 Sep; 83(3):709-717.
    View in: PubMed
    Score: 0.055
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.